Events

Flanders, Belgium and CERN
NOV
Fri
30
08:30 - 18:00

This was 7 years ago

Location

Koninklijke Vlaamse Academie van België voor Wetenschappen en Kunsten 



Hertogsstraat 1



1000 Brussel


Programmes
RI Horizon 2020

This symposium is part of the 2018 Thinkers' programme on ‘Flanders, Belgium and CERN’ led by Walter Van Doninck (former Vice President of the CERN Council and Thinker-in-Residence).

CERN is a role model for international scientific research in Europe and beyond. This symposium will offer both a general introduction to CERN as well as a Belgian and Flemish perspective. What is the legacy of CERN for mankind? What is its scientific and industrial return for Belgium? What discoveries and technological improvements await in the future? National and international scientists reflect during the symposium resulting from the KVAB Thinkers' Programme "Flanders, Belgium and CERN" with Walter Van Doninck.

The programme, recordings and presentations can be found here.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of iCARE4CVD: Thomas More participates in research on improving patient care

iCARE4CVD: Thomas More participates in research on improving patient care

Funded under Horizon Europe’s Innovative Health Initiative (HORIZON-JU-IHI-2022-02-01) and running from 2023 to 2028, the iCARE4CVD project aims to improve patient care across the board, starting from those at risk of developing cardiovascular disease to those with advanced heart failure. Thomas More University of Applied Sciences plays an important role in the project focusing data analysis and AI modeling as well as on the implementation of Patient-Reported Outcome Measures and Patient-Reported Experience Measures. Find out more in the full article.